痴呆症护理研究和心理社会因素
1Ohio State University Wexner Medical Center, Columbus, OH, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
针对阿尔茨海默病 (AD) 的新型定向疗法提供个性化治疗,但需要加强医疗保健能力. 通过数字评估和生物标志物的早期识别,以及仔细的患者-提供者讨论,对于有效的早期AD管理至关重要.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 医疗保健系统 医疗保健系统
背景情况:
- 阿尔茨海默病 (AD) 治疗正在随着针对的疾病修饰疗法 (DMT) 的引入而发展.
- 这些新疗法承诺个性化的早期干预策略.
- 成功实施需要对医疗保健系统进行重大调整.
研究的目的:
- 概述了将tau向DMT整合到AD护理中的要求.
- 强调需要加强医疗保健能力和以患者为中心的方法.
- 讨论生物标志物和个性化决策的关键作用.
主要方法:
- 审查当前和新兴的AD治疗模式.
- 对医疗保健系统的分析要求新的DMT.
- 讨论诊断和监测工具,包括数字认知评估和生物标志物 (血液,CSF,PET).
- 考虑影响治疗选择和患者管理的因素.
主要成果:
- 以为向的DMT进行个性化的AD治疗需要强大的医疗保健基础设施.
- 早期识别和有效的转诊途径至关重要.
- 生物标志物概况,患者偏好和风险效益分析是治疗决策的关键.
- 需要专门的跟踪系统来监测进展和不良事件.
结论:
- 针对tau的DMT的整合需要向分散的护理模式转变,并提高医疗保健系统的能力.
- 个性化治疗决策必须基于证据,考虑全面的生物标志物概况和患者特定因素.
- 持续监测和适应性治疗计划对于优化患者的治疗结果和阿尔茨海默病管理的独立性至关重要.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
相关概念视频
01:30Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
01:29Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
01:30Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
01:29Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K